GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Sold by Man Group plc

Man Group plc lessened its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 69.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 158,891 shares of the company's stock after selling 369,072 shares during the quarter. Man Group plc's holdings in GE HealthCare Technologies were worth $12,422,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in the company. Nissay Asset Management Corp Japan ADV lifted its position in GE HealthCare Technologies by 11.7% during the fourth quarter. Nissay Asset Management Corp Japan ADV now owns 103,691 shares of the company's stock valued at $8,244,000 after purchasing an additional 10,832 shares during the period. NorthRock Partners LLC lifted its stake in GE HealthCare Technologies by 127.0% during the fourth quarter. NorthRock Partners LLC now owns 6,253 shares of the company's stock worth $489,000 after purchasing an additional 3,498 shares during the last quarter. Occudo Quantitative Strategies LP acquired a new stake in GE HealthCare Technologies during the 4th quarter worth $2,480,000. OMERS ADMINISTRATION Corp lifted its stake in shares of GE HealthCare Technologies by 22.3% in the 4th quarter. OMERS ADMINISTRATION Corp now owns 17,354 shares of the company's stock worth $1,357,000 after acquiring an additional 3,167 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in GE HealthCare Technologies by 2.7% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 512,985 shares of the company's stock worth $40,106,000 after buying an additional 13,651 shares in the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on GEHC. Morgan Stanley lowered their target price on shares of GE HealthCare Technologies from $86.00 to $78.00 and set an "equal weight" rating for the company in a report on Tuesday, May 6th. Evercore ISI reduced their price target on shares of GE HealthCare Technologies from $96.00 to $85.00 and set an "outperform" rating for the company in a research note on Thursday, May 1st. Piper Sandler dropped their target price on shares of GE HealthCare Technologies from $104.00 to $88.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 23rd. The Goldman Sachs Group lowered their price target on GE HealthCare Technologies from $94.00 to $82.00 and set a "buy" rating for the company in a research note on Thursday, May 1st. Finally, BTIG Research set a $95.00 price target on shares of GE HealthCare Technologies and gave the company a "buy" rating in a report on Monday, April 14th. Three analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, GE HealthCare Technologies currently has an average rating of "Moderate Buy" and a consensus price target of $88.27.

GE HealthCare Technologies Trading Down 1.7%

NASDAQ GEHC traded down $1.25 during trading on Tuesday, hitting $71.85. The company had a trading volume of 3,268,213 shares, compared to its average volume of 3,422,895. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $94.80. The company has a market cap of $32.90 billion, a price-to-earnings ratio of 16.59, a price-to-earnings-growth ratio of 3.19 and a beta of 1.21. The company's fifty day moving average is $70.87 and its 200-day moving average is $79.96. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings data on Wednesday, April 30th. The company reported $1.01 EPS for the quarter, topping the consensus estimate of $0.91 by $0.10. The firm had revenue of $4.78 billion for the quarter, compared to the consensus estimate of $4.66 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The business's revenue for the quarter was up 2.7% compared to the same quarter last year. During the same quarter last year, the company earned $0.90 earnings per share. On average, sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, May 15th. Investors of record on Friday, April 25th were paid a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.19%. The ex-dividend date was Friday, April 25th. GE HealthCare Technologies's dividend payout ratio (DPR) is presently 2.95%.

GE HealthCare Technologies announced that its Board of Directors has authorized a stock repurchase program on Wednesday, April 30th that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the company to repurchase up to 3.1% of its shares through open market purchases. Shares buyback programs are often a sign that the company's board believes its shares are undervalued.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.